Exit
Register
Login
2025 MaTOS Lung | Session II | Early-Stage Resectable Lung Cancer
Complete Pathologic Response and Other Surrogates to Evaluate Success of Neoadjuvant Therapy?
Surgical Outcomes of Perioperative Therapy in the Era of Immunotherapy
Debate: In 2025, Is Perioperative Immunotherapy the New Standard of Care? (Yes)
Debate: In 2025, Is Perioperative Immunotherapy the New Standard of Care? (No)
How To Identify Those Patients Who Need Adjuvant Therapy?
Q & A Session
Finish Course
You need to enroll in this course to view this chapter
This chapter is locked
Complete Pathologic Response and Other Surrogates to Evaluate Success of Neoadjuvant Therapy?
Enroll for $5,000.00
0% Course Complete